BIGBEAR
PHARMACEUTICALS
Ivosidenib can reduce the production of the oncogenic metabolite 2-HG by selectively targeting and inhibiting the activity of the mutant IDH1 enzyme.
AuthenticGuaranteeFast DeliveryPrivacy Evonib, a highly selective IDH1 gene mutation inhibitor, blocks abnormal metabolic processes in tumor cells through targeted action. It is primarily u···【Read More】
Update: 12 Mar,2026Source: Haiou HealthViews: 70
Evonib is an IDH1-targeting inhibitor. This drug works by precisely targeting the mutated IDH1 protein, blocking abnormal metabolic pathways in tumor ···【Read More】
Update: 12 Mar,2026Source: Haiou HealthViews: 70
Copyright2024@ BIGBEAR All right reserved BIGBEAR
